Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia

Blood

Volumn 126, Issue 15, 2015, Pages 1770-1776

  Karol, Seth E ^a   Yang, Wenjian ^a   Van Driest, Sara L ^b   Chang, Tamara Y ^a   Kaste, Sue ^a,c   Bowton, Erica ^d   Basford, Melissa ^d   Bastarache, Lisa ^e   Roden, Dan M ^b,f   Denny, Joshua C ^b,e   Larsen, Eric ^g   Winick, Naomi ^h   Carroll, William L ⁱ   Cheng, Cheng ^a   Pei, Deqing ^a   Fernandez, Christian A ^a   Liu, Chengcheng ^a   Smith, Colton ^a   Loh, Mignon L ^j   Raetz, Elizabeth A ^k   Hunger, Stephen P ^l   Scheet, Paul ^m   Jeha, Sima ^a   Pui, Ching Hon ^a   Evans, William E ^a   Devidas, Meenakshi ⁿ   Mattano, Leonard A ^o   Relling, Mary V ^a   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d Office of Research   (United States)

^e Department of Biomedical Informatics ^*  (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MAINE MEDICAL CENTER   (United States)

^h UNIVERSITY OF TEXAS AT DALLAS   (United States)

ⁱ NEW YORK UNIVERSITY   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^l CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^m UNIVERSITY OF TEXAS   (United States)

ⁿ UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^o HARP Pharma Consulting   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUTAMATE RECEPTOR; BIOLOGICAL MARKER; DEXAMETHASONE; GRIN3A PROTEIN, HUMAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTERY EMBOLISM; ARTICLE; BONE NECROSIS; BRAIN ISCHEMIA; CHILD; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; FEMALE; GENE LOCUS; GENETIC RISK; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS; CANCER STAGING; CHEMICALLY INDUCED; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOLOGY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RISK FACTOR;

BIOMARKERS; CHILD; COHORT STUDIES; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLUCOCORTICOIDS; HUMANS; MALE; META-ANALYSIS AS TOPIC; NEOPLASM STAGING; OSTEONECROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECEPTORS, N-METHYL-D-ASPARTATE; RISK FACTORS;

EID: 84984608981     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-05-643601     Document Type: Article

References (48)

1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006; 354(2):166-178.
2. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26): 2730-2741.
3. Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol. 2012;30(14):1663-1669.
4. Schrappe M, Moricke A, Reiter A, et al. Key treatment questions in childhood acute lymphoblastic leukemia: Results in 5 consecutive trials performed by the all-bfm study group from 1981 to 2000. Klin Padiatr. 2013;225(suppl 1): S62-S72.
5. Vora A, Goulden N, Mitchell C, et al. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2014;15(8):809-818.
6. Vaitkevičiene G, Forestier E, Hellebostad M, et al; Nordic Society of Paediatric Haematology and Oncology (NOPHO). High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies. Eur J Haematol. 2011;86(1): 38-46.
7. Kawedia JD, Kaste SC, Pei D, et al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2011;117(8):2340-2347, quiz 2556.
8. Mattano LA Jr, Devidas M, Nachman JB, et al; Children's Oncology Group. Effect of alternateweek versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol. 2012; 13(9):906-915.
9. Patel B, Richards SM, Rowe JM, Goldstone AH, Fielding AK. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis. Leukemia. 2008;22(2):308-312.
10. Relling MV, Yang W, Das S, et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol. 2004;22(19):3930-3936.
11. Mattano LA Jr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol. 2000;18(18):3262-3272.
12. te Winkel ML, Pieters R, Hop WC, et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2011; 29(31):4143-4150.
13. Drescher W, Schlieper G, Floege J, Eitner F. Steroid-related osteonecrosis-an update. Nephrol Dial Transplant. 2011;26(9):2728-2731.
14. Shigemura T, Nakamura J, Kishida S, et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology (Oxford). 2011;50(11):2023-2028.
15. Powell C, Chang C, Naguwa SM, Cheema G, Gershwin ME. Steroid induced osteonecrosis: an analysis of steroid dosing risk. Autoimmun Rev. 2010;9(11):721-743.
16. Roden DM, Pulley JM, Basford MA, et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther. 2008;84(3):362-369.
17. Pulley J, Clayton E, Bernard GR, Roden DM, Masys DR. Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin Transl Sci. 2010;3(1):42-48.
18. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet. 2006;78(4):629-644.
19. Liu EY, Li M, Wang W, Li Y. MaCH-admix: genotype imputation for admixed populations. Genet Epidemiol. 2013;37(1):25-37.
20. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5(6):e1000529.
21. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000;155(2):945-959.
22. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17): 2190-2191.
23. Denny JC, Ritchie MD, Basford MA, et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics. 2010;26(9): 1205-1210.
24. Denny JC, Bastarache L, Ritchie MD, et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol. 2013;31(12):1102-1110.
25. Chang T, Yang W, Sara VDL, et al. Glutamate receptor polymorphisms contribute to glucocorticoid-associated osteonecrosis. Blood. 2014;124(21):367.
26. Mirkov S, Myers JL, Ramírez J, Liu W. SNPs affecting serum metabolomic traits may regulate gene transcription and lipid accumulation in the liver. Metabolism. 2012;61(11):1523-1527.
27. Zhou J, Ye S, Fujiwara T, Manolagas SC, Zhao H. Steap4 plays a critical role in osteoclastogenesis in vitro by regulating cellular iron/reactive oxygen species (ROS) levels and cAMP response element-binding protein (CREB) activation. J Biol Chem. 2013;288(42):30064-30074.
28. Narvaez CJ, Simmons KM, Brunton J, Salinero A, Chittur SV, Welsh JE. Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J Cell Physiol. 2013;228(10):2024-2036.
29. Martin RI, Owens WA, Cunnington MS, Mayosi BM, Koref MS, Keavney BD. Chromosome 16q22 variants in a region associated with cardiovascular phenotypes correlate with ZFHX3 expression in a transcript-specific manner. BMC Genet. 2014;15(1):136.
30. Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina JA, Moran MA, Ruiz-Irastorza G. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2014;53(8):1470-1476.
31. Kamata N, Oshitani N, Sogawa M, et al. Usefulness of magnetic resonance imaging for detection of asymptomatic osteonecrosis of the femoral head in patients with inflammatory bowel disease on long-term corticosteroid treatment. Scand J Gastroenterol. 2008;43(3):308-313.
32. Chen SH, Pei D, Yang W, et al. Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity. Clin Pharmacol Ther. 2010;88(2):191-196.
33. Rajic V, Debeljak M, Goricar K, Jazbec J. Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia [published online ahead of print March 30, 2015]. Leuk Lymphoma. 2015;1-6.
34. Yang L, Panetta JC, Cai X, et al. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J Clin Oncol. 2008;26(12):1932-1939.
35. Liu C, Kawedia JD, Cheng C, et al. Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia. 2012; 26(11):2303-2309.
36. Smith RW, Margulis RR, Brennan MJ, Monto RW. The influence of ACTH and cortisone on certain factors of blood coagulation. Science. 1950; 112(2907):295-297.
37. Yamamoto T, Hirano K, Tsutsui H, Sugioka Y, Sueishi K. Corticosteroid enhances the experimental induction of osteonecrosis in rabbits with Shwartzman reaction. Clin Orthop Relat Res. 1995;(316):235-243.
38. Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum. 1997; 40(11):2055-2064.
39. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res. 2001;(386): 19-33.
40. Yun SI, Yoon HY, Jeong SY, Chung YS. Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. J Bone Miner Metab. 2009;27(2): 140-148.
41. Janke LJ, Liu C, Vogel P, et al. Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis. Am J Pathol. 2013;183(1):19-25.
42. French D, Hamilton LH, Mattano LA Jr, et al; Children's Oncology Group. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2008; 111(9):4496-4499.
43. Bond J, Adams S, Richards S, Vora A, Mitchell C, Goulden N. Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2011;118(9):2632-2633.
44. Brakspear KS, Mason DJ. Glutamate signaling in bone. Front Endocrinol (Lausanne). 2012;3:97.
45. Sharp CD, Houghton J, Elrod JW, et al. N-methyl-D-aspartate receptor activation in human cerebral endothelium promotes intracellular oxidant stress. Am J Physiol Heart Circ Physiol. 2005;288(4): H1893-H1899.
46. Olkku A, Bodine PV, Linnala-Kankkunen A, Mahonen A. Glucocorticoids induce glutamine synthetase expression in human osteoblastic cells: a novel observation in bone. Bone. 2004; 34(2):320-329.
47. Gaunitz F, Heise K, Schumann R, Gebhardt R. Glucocorticoid induced expression of glutamine synthetase in hepatoma cells. Biochem Biophys Res Commun. 2002;296(4):1026-1032.
48. Lin YJ, Chang JS, Liu X, et al. Association between GRIN3A gene polymorphism in Kawasaki disease and coronary artery aneurysms in Taiwanese children. PLoS One. 2013;8(11): e81384.